| CAS ID: | 218600-53-4 |
| Molecular Formula: | C32H43NO4 |
| Molecular Weight: | 505.7 g/mol |
| Monoisotopic Mass: | 505.3192 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | BARDOXOLONE METHYL | RTA-402 | CDDO-Me | NSC 713200 | RTA 402 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1 | See All |
| InChI Key: | WPTTVJLTNAWYAO-KPOXMGGZSA-N | |
| Smiles: | COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]3C(=O)C=C4[C@@](C)(CC[C@H]5C(C)(C)C(=O)C(=C[C@]45C)C#N)[C@]3(C)CC2 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT02036970 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | January 15, 2014 | Last Verified | January 3, 2019 |
| Sponsor | Reata Pharmaceuticals, Inc. | ||
| PubChem: | 400769 |
| ChEMBL: | CHEMBL1762621 |